Search for: "PFIZER"
Results 2881 - 2900
of 4,635
Sort by Relevance
|
Sort by Date
22 Nov 2010, 7:48 am
Pfizer did not respond to a request for comment. [read post]
22 Nov 2010, 2:16 am
This included, however, the civil portion of the Pfizer settlement which was announced in September, 2009, but paid after the start of FY 2010. [read post]
19 Nov 2010, 11:43 am
Pfizer, Inc. [read post]
18 Nov 2010, 12:33 pm
Pfizer fraudulently concealed the negative testing and information that formed the basis of the UCL claim, according to the court. [read post]
16 Nov 2010, 5:45 am
The court relied heavily on Pfizer, Inc. v. [read post]
15 Nov 2010, 9:34 pm
Part V argues that Pfizer v. [read post]
14 Nov 2010, 5:57 am
It was later acquired by J&J when the company acquired Pfizer’s consumer healthcare sector. [read post]
12 Nov 2010, 12:58 pm
Companies are also starting to include provisions in their bylaws such as disclosure of hedging as a condition to presentation of nominations or other business (Pfizer 6/25/08 8-K is a good example). [read post]
New federal UCL "fraudulent" prong decision: In re Neurotonin Marketing & Sales Practices Litigation
12 Nov 2010, 5:00 am
In this post-trial decision, the court orders the defendant (Pfizer) to pay $95 million in restitution to the plaintiff (Kaiser Foundation Health Plan) for violations of the UCL's "fraudulent" prong. [read post]
11 Nov 2010, 12:54 pm
Pfizer Inc., 2009 WL 3230611, at *8 (W.D. [read post]
11 Nov 2010, 6:00 am
Industry representatives from Pfizer, Biotechnology Industry Organization, Johnson & Johnson, and the Pharmaceutical Research and Manufacturers of America, suggested that the information sharing phase may not be needed for applications with few matters requiring further discussion, or those likely to receive a complete response from the agency. [read post]
10 Nov 2010, 4:01 am
Riddell, Inc. v. [read post]
10 Nov 2010, 1:11 am
Highlights this week included: US government intervenes in patentability of genes – AMP v USPTO (Patent Baristas) (Holman’s Biotech IP Blog) (Intellectual Property Law Blog) (Inovia) (BlawgIT) (IP Osgoode) Temodar (Temozolomide) – US: CAFC limits prosecution laches defense: Cancer Research Technology v Barr Laboratories (Inventive Step) (IPBiz) (Patently-O) (SmartBrief) Italian antitrust authority opens preliminary investigation into whether Pfizer subsidiary artificially… [read post]
8 Nov 2010, 7:35 am
In a case involving certain chemical analogs and optical isomers, Chief Judge Sleet construed the following terms: - "S-(+)-4-amino-3-(2-methylpropyl) butanoic acid as a single optical isomer" - "4-amino-3-(2-methylpropyl) butanoic acid" Pfizer, Inc. v. [read post]
8 Nov 2010, 5:00 am
Pfizer, Inc., 881 N.E.2d 812, 818 (Mass. [read post]
7 Nov 2010, 7:11 am
Pfizer: Adoption and the FMLA The decision is Dotson v. [read post]
5 Nov 2010, 3:43 pm
Pfizer says the problem is not widespread, and has been reported fewer than three times per million bottles of Lipitor. [read post]
5 Nov 2010, 1:04 pm
However, Ohio Attorney General Richard Cordray, who has been active in bringing securities lawsuits against financial firms, was defeated.In other political-related news this week, Walden Asset Management, Domini Social Investment, and a coalition of religious and ESG investors filed shareholder proposals at Accenture, IBM, Pfizer, and Pepsi that question the companies' membership on the board of the U.S. [read post]
5 Nov 2010, 4:29 am
Political Spending Shareholder Proposals: Chamber Board Members Targeted Yesterday, a group of investors issued this press release noting that shareholder proposals regarding political spending were being filed at four companies - Accenture, IBM, Pepsi and Pfizer - who have directors that also sit on the board of the Chamber of Commerce. [read post]
4 Nov 2010, 1:38 pm
Pfizer, Inc.) [read post]
